The International Agency for Research on Cancer (IARC), under the World Health Organization, is expected to classify aspartame, a widely-used artificial sweetener, as "possibly carcinogenic to humans" in July, reliable sources disclosed. Found in numerous food products, aspartame's classification aims to spur further investigation into its health effects.
Aspartame is found in numerous products, including Coca-Cola diet soda, Müller Light yogurts, Mars' Extra chewing gum, and more. While the IARC ruling, which was finalized earlier this month, aims to evaluate the potential hazards based on published evidence, it does not consider the safe consumption limits. Separate advice for individuals regarding the safe intake of aspartame is provided by the Joint WHO and Food and Agriculture Organization's Expert Committee on Food Additives (JECFA), as well as determinations from national regulators.
On the 14th of July, both the IARC and JECFA are expected to announce their findings. JECFA has historically declared aspartame safe for consumption within accepted daily limits since 1981. To pose a risk, an adult weighing 60 kg (132 pounds) would need to consume an excessive daily amount of 12 to 36 cans of diet soda, depending on the aspartame content in each beverage.
Although the IARC and JECFA findings remain confidential until July, an IARC spokesperson disclosed that these results are complementary and represent important steps in understanding the possible carcinogenicity of aspartame. However, it is crucial to note that the IARC is not a food safety authority. The WHO's JECFA is currently conducting a comprehensive food safety review of aspartame, and any conclusions should be drawn only after both reports are published.
Despite the ongoing debate, it is worth mentioning that aspartame has undergone extensive research, endorsed as safe by over 90 food safety agencies worldwide. The European Food Safety Authority conducted the most comprehensive safety evaluation of aspartame to date.
It is worth noting that a recent observational study conducted in France among 100,000 adults showed a potential association between artificial sweeteners, particularly aspartame and acesulfame-K, and increased cancer risk.
Together, these developments shed light on the upcoming assessment of aspartame's potential risks and its impact on consumer safety.
According to the sources closely associated with the International Agency for Research on Cancer (IARC), the inclusion of aspartame as a potential carcinogen is aimed at stimulating further investigation. This revelation comes just a month after the World Health Organization (WHO) released guidelines cautioning individuals against using non-sugar sweeteners for weight management.
Photo: Brett Jordan/Unsplash


Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Pfizer Secures $10 Billion Deal for Obesity Drug Developer Metsera, Outbids Novo Nordisk
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate
Oil Prices Hold Steady in Asia as Geopolitical Tensions Support Market
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Eli Lilly Becomes First Pharma Giant to Hit $1 Trillion Amid Soaring Weight-Loss Drug Demand
China to Tighten Crude Steel Output Controls and Export Regulation Through 2030
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Eli Lilly’s Weight-Loss Pill Nears Fast-Track FDA Approval as Profits Surge on Global Demand
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Asian Markets Rise as AI Rally Caps 2025, Gold and Silver Hit Record Highs
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Canada Loses Measles-Free Status After Nearly 30 Years Amid Declining Vaccination Rates
Wall Street Ends Post-Christmas Session Flat as Investors Eye Santa Claus Rally 



